William P. Sheridan

2009

In 2009, William P. Sheridan earned a total compensation of $510.4K as Senior Vice President and Chief Medical Officer at BioCryst Pharmaceuticals, a 16% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$92,894
Option Awards$20,250
Salary$385,050
Other$12,250
Total$510,444

Sheridan received $385.1K in salary, accounting for 75% of the total pay in 2009.

Sheridan also received $92.9K in non-equity incentive plan, $20.3K in option awards and $12.3K in other compensation.

Rankings

In 2009, William P. Sheridan's compensation ranked 6,805th out of 9,885 executives tracked by ExecPay. In other words, Sheridan earned more than 31.2% of executives.

ClassificationRankingPercentile
All
6,805
out of 9,885
31st
Division
Manufacturing
2,504
out of 3,690
32nd
Major group
Chemicals And Allied Products
550
out of 866
37th
Industry group
Drugs
377
out of 638
41st
Industry
Biological Products, Except Diagnostic Substances
73
out of 133
45th
Source: SEC filing on April 9, 2012.

Sheridan's colleagues

We found four more compensation records of executives who worked with William P. Sheridan at BioCryst Pharmaceuticals in 2009.

2009

Stuart Grant

BioCryst Pharmaceuticals

Chief Financial Officer

2009

Jon Stonehouse

BioCryst Pharmaceuticals

Chief Executive Officer

2009

Yarlagadda Babu

BioCryst Pharmaceuticals

Vice President, Drug Discovery

2009

David McCullough

BioCryst Pharmaceuticals

Vice President, Strategic Planning, Commercialization and Corporate Development

News

You may also like